I am very interested in what members of board think about the following question. Is the IND or the hope of a ngio vaccine essential for the uplist of NGIO to the Nasdaq? Do we have enough substance with everything else to get there without the vaccine play.
We were at $2 before all the vaccine noise. Honestly I would be very happy with that right now. It would be great if MMPJOE could provide input as much as he can within quiet time limits and guidance from his legal team.